Fuente: Fortune
The FDA has cleared Merck’s Lipfendra for patients whose artery‑clogging cholesterol remains high despite statins.
Leer en la Fuente
Noticias Relacionadas
Lista de Noticias
Fuente: Fortune
The FDA has cleared Merck’s Lipfendra for patients whose artery‑clogging cholesterol remains high despite statins.